Adverse Drug Reactions Advisory Committee (ADRAC)

The Adverse Drug Reactions Advisory Committee (ADRAC) is a subcommittee of the Australian Drug Evaluation Committee (ADEC) <http://www.tga.gov.au/docs/html/adec/adec.htm> and was formed in 1970 to advise the TGA on the safety of medicines. It is composed of independent medical experts who have expertise in areas of importance to the evaluation of medicine safety.

ADRAC membership

The current membership of the Committee is:

• Professor Duncan Topliss (Chair), Endocrinologist
• Associate Professor Peter Pillans, Clinical Pharmacologist
• Dr Dana Wainwright, Specialist physician
• Associate Professor Cecilie Lander, Neurologist
• Professor John McNeil, Clinical epidemiologist
• Dr Michael Gold, Specialist immunologist/paediatrician
• Associate Professor Simone Strasser, Gastroenterologist
• Dr Vicki Kotsirilos, General Practitioner with an interest in complementary medicine

Contacting ADRAC

• Email: adrac@tga.gov.au
• Phone: 1800 044 114
• Fax: 02 6232 8392

Top of page

Reporting to ADRAC

• What to report <http://www.tga.gov.au/adr/report.htm>
• What information to include in a report <http://www.tga.gov.au/adr/repinfo.htm>
• How to report an adverse drug reaction ("blue card") <http://www.tga.gov.au/adr/bluecard.htm>
• What happens to a report <http://www.tga.gov.au/rephap.htm>
• Guidelines for sponsors <http://www.tga.gov.au/pharmaco.htm>

ADRAC meeting dates

Information/statements from ADRAC

• Australian Adverse Drug Reactions Bulletin <http://www.tga.gov.au/adr/aadrb.htm>
• Use of SSRI antidepressants in children and adolescents - updated 15 October 2004 <http://www.tga.gov.au/adr/adrac_ssri.htm>
  15 October 2004
• Use of SSRI antidepressants in children and adolescents - updated 17 June 2004 <http://www.tga.gov.au/adr/adrac_ssri_040617.htm>
  17 June 2004
• Use of SSRI antidepressants in children and adolescents <http://www.tga.gov.au/adr/adrac_ssri_040311.htm>
  11 March 2004

Top of page